세계의 미생물 원료의약품 시장 보고서(2025년)

Microbial API Global Market Report 2025

US $ 4,490 ￦ 6,371,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,209,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,048,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

미생물 원료의약품 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 8.1%의 CAGR로 931억 2,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 제약 산업에서의 응용 분야 증가, 만성질환의 유병률 증가, 의료비 증가, 첨단 의료 인프라에 대한 접근성 증가, 감염성 질환의 증가, 항생제 내성 등에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 발효 및 다운스트림 처리 기술의 발전, 미생물 발효 기술의 혁신, 바이오 공정에 대한 투자, 분자생물학 및 합성생물학의 발전, 제품 혁신 등이 있습니다.

만성질환의 유병률 증가는 향후 몇 년 동안 미생물 원료의약품 시장의 성장을 촉진할 것으로 예상됩니다. 만성질환은 장기적인 건강 문제나 지속적인 영향을 미치는 질병을 말합니다. 만성질환의 증가는 인구 고령화, 좌식 생활습관, 영양 부족, 환경 변화, 질병 발견 및 진단의 개선 등 다양한 요인에 기인합니다. 미생물 유래 API는 효과적인 치료법을 개발하는 데 사용되는 미생물 유래의 치료 특성으로 인해 이러한 만성질환의 관리에 점점 더 많이 활용되고 있습니다. 예를 들어, 스위스에 본부를 둔 정부 간 기구인 세계보건기구(WHO)에 따르면, 2050년까지 새로 발생하는 암 환자는 3,500만 명을 넘어 2022년 추정치인 2,000만 명에서 77% 증가할 것으로 예측하고 있습니다. 이처럼 만성질환의 유병률 증가가 미생물원료의약품 시장의 성장을 촉진하고 있습니다.

미생물 원료의약품 시장의 주요 기업들은 약효를 높이고, 제제의 안정성을 향상시키며, 규제 기준을 충족시키기 위해 부형제와 같은 새로운 API 제품을 개발하고 있습니다. 부형제는 안정화, 제제 증량, 치료 특성 향상, 제조 보조 등 다양한 목적으로 의약품의 유효 성분과 함께 배합되는 물질입니다. 예를 들어, 2023년 10월 스위스 화학회사 클라리언트(Clarient)는 의약품 유효성분(API)의 안정성과 용해도를 향상시키는 새로운 부형제 시리즈를 출시하였습니다. 이번 확장에는 API의 전달 및 생체 이용률 문제를 해결하기 위해 설계된 세 가지 새로운 VitiPure 부형제가 포함되며, 경구, 국소, 비경구 등 다양한 투여 용도에 사용할 수 있도록 설계되었습니다. 이 부형제는 약물전달, 특히 mRNA 백신이나 생물학적 제제와 같은 민감한 약물에 효과적인 운반체 시스템을 제공함으로써 제약 산업을 지원하는 것을 목표로 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 미생물 원료의약품 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 미생물 원료의약품 시장 : 성장률 분석
• 세계의 미생물 원료의약품 시장 실적 : 규모와 성장, 2019-2024
• 세계의 미생물 원료의약품 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 미생물 원료의약품 전체 시장(TAM)

제6장 시장 세분화

• 세계의 미생물 원료의약품 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 항체
• 펩타이드
• 단백질
• 소분자
• 백신
• 세계의 미생물 원료의약품 시장 : 호스트별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 포유류
• 세균성
• 진균
• 세계의 미생물 원료의약품 시장 : 사이트별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 사내
• 아웃소싱
• 세계의 미생물 원료의약품 시장 : 분자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 혁신적
• 제네릭
• 세계의 미생물 원료의약품 시장 : 최종 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 제약회사
• 바이오의약품 기업
• 기타 용도
• 세계의 미생물 원료의약품 시장, 항체 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 단클론항체
• 다클론항체
• 세계의 미생물 원료의약품 시장, 펩타이드 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 치료용 펩타이드
• 진단용 펩타이드
• 세계의 미생물 원료의약품 시장, 단백질 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 재조합 단백질
• 네이티브 단백질
• 세계의 미생물 원료의약품 시장, 소분자 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 항생제
• 항진균제
• 항바이러스제
• 세계의 미생물 원료의약품 시장, 백신 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세균 백신
• 바이러스 백신

제7장 지역별·국가별 분석

• 세계의 미생물 원료의약품 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 미생물 원료의약품 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 미생물 원료의약품 시장 : 경쟁 구도
• 미생물 원료의약품 시장 : 기업 개요
  • BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • Merck& Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

• AstraZeneca Plc
• GlaxoSmithKline Plc
• Eli Lilly And Company
• Boehringer Ingelheim GmbH
• Amgen Inc.
• Evonik Industries AG
• TEVA Pharmaceutical industries Ltd.
• Lonza Group AG
• Catalent Inc.
• CSPC Pharmaceutical Group Ltd.
• Patheon
• Dr. Reddy's Laboratories Ltd.
• Siegfried Ltd.
• Recipharm AB
• Shandong Lukang Pharmaceutical Co. Ltd.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 미생물 원료의약품 시장 2029 : 새로운 기회를 제공하는 국가
• 미생물 원료의약품 시장 2029 : 새로운 기회를 제공하는 부문
• 미생물 원료의약품 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

Microbial APIs (active pharmaceutical ingredients) are pharmaceutical compounds produced through microbial fermentation processes. These compounds are created by cultivating microorganisms such as bacteria, fungi, or yeast, and then extracting the desired compound.

The main types of microbial APIs include antibodies, peptides, proteins, small molecules, and vaccines. An antibody is a protein produced by the immune system that binds to specific molecules called antigens. These APIs can be derived from different hosts, including mammalian, bacterial, and fungal sources, and can be produced in various sites, either in-house or outsourced. They encompass both innovative and generic molecules and are utilized by several end-users, including pharmaceutical and biopharmaceutical companies, among others.

The microbial API market research report is one of a series of new reports from The Business Research Company that provides microbial API market statistics, including microbial API industry global market size, regional shares, competitors with a microbial API market share, detailed microbial API market segments, market trends and opportunities, and any further data you may need to thrive in the microbial API industry. This microbial API market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microbial API market size has grown strongly in recent years. It will grow from $62.9 billion in 2024 to $68.16 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increased demand for drugs, an increase in the focus of government on healthcare and pharmaceuticals, an increased need to meet nutritional requirements, sustainability and cost-efficiency, and a rise in demand for biological drugs.

The microbial API market size is expected to see strong growth in the next few years. It will grow to $93.12 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing applications in the pharmaceutical industry, the rising prevalence of chronic conditions, increasing health care expenditure, increasing access to advanced medical infrastructure, increasing infections and antibiotic resistance. Major trends in the forecast period include advancements in fermentation and downstream processing technologies, innovations in microbial fermentation technologies, investments in bioprocessing, advancements in molecular biology and synthetic biology, and product innovation.

The growing prevalence of chronic conditions is anticipated to drive the expansion of the microbial API market in the coming years. Chronic conditions are long-term health issues or diseases that have persistent effects. The increase in chronic conditions can be attributed to various factors, including aging populations, sedentary lifestyles, poor nutrition, environmental changes, and improved disease detection and diagnosis. Microbial APIs are being increasingly utilized in managing these chronic conditions due to their therapeutic properties derived from microorganisms, which are used to develop effective treatments. For example, according to the World Health Organization, a Switzerland-based intergovernmental organization, it is projected that by 2050, there will be over 35 million new cancer cases, marking a 77% rise from the estimated 20 million cases in 2022. Thus, the rising prevalence of chronic conditions is fueling the growth of the microbial API market.

Leading companies in the microbial API market are developing novel API products, such as excipients, to enhance drug efficacy, improve formulation stability, and meet regulatory standards. Excipients are substances formulated alongside the active ingredient of medication to serve various purposes, including stabilization, bulking up formulations, enhancing therapeutic properties, and aiding in manufacturing. For instance, in October 2023, Clariant, a Switzerland-based chemical company, launched a new range of excipients to improve the stability and solubility of active pharmaceutical ingredients (APIs). This expansion includes three new VitiPure excipients designed to address challenges in API delivery and bioavailability, catering to various dosage applications such as oral, topical, and parenteral administration. These excipients aim to support the pharmaceutical industry by providing effective carrier systems for drug delivery, especially for sensitive medications such as mRNA vaccines and biologics.

In February 2022, Recipharm, a Sweden-based pharmaceutical contract development and manufacturing organization (CDMO), acquired Arranta Bio MA LLC for an undisclosed amount. This acquisition aims to enhance Recipharm's biologics manufacturing capabilities and establish a robust US platform for providing innovative drug developers with differentiated contract development and manufacturing services for advanced therapy medicinal products (ATMPs). Arranta Bio MA LLC is a US-based biotechnology company that provides microbial APIs.

Major companies operating in the microbial API market are BASF SE, Merck& Co Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, GlaxoSmithKline Plc, Eli Lilly And Company, Boehringer Ingelheim GmbH, Amgen Inc., Evonik Industries AG, TEVA Pharmaceutical industries Ltd., Lonza Group AG, Catalent Inc., CSPC Pharmaceutical Group Ltd., Patheon, Dr. Reddy's Laboratories Ltd., Siegfried Ltd., Recipharm AB, Shandong Lukang Pharmaceutical Co. Ltd., Tianjin Tianyao Pharmaceuticals Co. Ltd., Xellia Pharmaceuticals, Kolon Life Science Inc., Royal DSM NV, Henan Topfond Pharmaceutical Co. Ltd.

Asia-Pacific was the largest region in the microbial API market in 2024. The regions covered in the microbial api market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the microbial API market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The microbial API market consists of sales of, glycerin, and hydrolyzed yeast protein, salvia sclarea oil, allantoin and other related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microbial API Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microbial api market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microbial api ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microbial api market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Antibody; Peptide; Protein; Small Molecule; Vaccine
• 2) By Host: Mammalian; Bacterial; Fungal
• 3) By Site: In-House; Outsourced
• 4) By Molecule: Innovative; Generic
• 5) By End-Use: Pharmaceutical Companies; Biopharmaceutical Companies; Other End-Uses
• Subsegments:
• 1) By Antibody: Monoclonal Antibodies; Polyclonal Antibodies
• 2) By Peptide: Therapeutic Peptides; Diagnostic Peptides
• 3) By Protein: Recombinant Proteins; Native Proteins
• 4) By Small Molecule: Antibiotics; Antifungals; Antivirals
• 5) By Vaccine: Bacterial Vaccines; Viral Vaccines
• Companies Mentioned: BASF SE; Merck& Co Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Microbial API Market Characteristics

3. Microbial API Market Trends And Strategies

4. Microbial API Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Microbial API Growth Analysis And Strategic Analysis Framework

• 5.1. Global Microbial API PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Microbial API Market Growth Rate Analysis
• 5.4. Global Microbial API Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Microbial API Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Microbial API Total Addressable Market (TAM)

6. Microbial API Market Segmentation

• 6.1. Global Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibody
• Peptide
• Protein
• Small Molecule
• Vaccine
• 6.2. Global Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mammalian
• Bacterial
• Fungal
• 6.3. Global Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In-House
• Outsourced
• 6.4. Global Microbial API Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Innovative
• Generic
• 6.5. Global Microbial API Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Other End-Uses
• 6.6. Global Microbial API Market, Sub-Segmentation Of Antibody, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Polyclonal Antibodies
• 6.7. Global Microbial API Market, Sub-Segmentation Of Peptide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Peptides
• Diagnostic Peptides
• 6.8. Global Microbial API Market, Sub-Segmentation Of Protein, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Proteins
• Native Proteins
• 6.9. Global Microbial API Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antifungals
• Antivirals
• 6.10. Global Microbial API Market, Sub-Segmentation Of Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Vaccines
• Viral Vaccines

7. Microbial API Market Regional And Country Analysis

• 7.1. Global Microbial API Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Microbial API Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Microbial API Market

• 8.1. Asia-Pacific Microbial API Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Microbial API Market

• 9.1. China Microbial API Market Overview
• 9.2. China Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Microbial API Market

• 10.1. India Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Microbial API Market

• 11.1. Japan Microbial API Market Overview
• 11.2. Japan Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Microbial API Market

• 12.1. Australia Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Microbial API Market

• 13.1. Indonesia Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Microbial API Market

• 14.1. South Korea Microbial API Market Overview
• 14.2. South Korea Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Microbial API Market

• 15.1. Western Europe Microbial API Market Overview
• 15.2. Western Europe Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Microbial API Market

• 16.1. UK Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Microbial API Market

• 17.1. Germany Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Microbial API Market

• 18.1. France Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Microbial API Market

• 19.1. Italy Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Microbial API Market

• 20.1. Spain Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Microbial API Market

• 21.1. Eastern Europe Microbial API Market Overview
• 21.2. Eastern Europe Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Microbial API Market

• 22.1. Russia Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Microbial API Market

• 23.1. North America Microbial API Market Overview
• 23.2. North America Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Microbial API Market

• 24.1. USA Microbial API Market Overview
• 24.2. USA Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Microbial API Market

• 25.1. Canada Microbial API Market Overview
• 25.2. Canada Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Microbial API Market

• 26.1. South America Microbial API Market Overview
• 26.2. South America Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Microbial API Market

• 27.1. Brazil Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Microbial API Market

• 28.1. Middle East Microbial API Market Overview
• 28.2. Middle East Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Microbial API Market

• 29.1. Africa Microbial API Market Overview
• 29.2. Africa Microbial API Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Microbial API Market, Segmentation By Host, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Microbial API Market, Segmentation By Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Microbial API Market Competitive Landscape And Company Profiles

• 30.1. Microbial API Market Competitive Landscape
• 30.2. Microbial API Market Company Profiles
  • 30.2.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck& Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Microbial API Market Other Major And Innovative Companies

• 31.1. AstraZeneca Plc
• 31.2. GlaxoSmithKline Plc
• 31.3. Eli Lilly And Company
• 31.4. Boehringer Ingelheim GmbH
• 31.5. Amgen Inc.
• 31.6. Evonik Industries AG
• 31.7. TEVA Pharmaceutical industries Ltd.
• 31.8. Lonza Group AG
• 31.9. Catalent Inc.
• 31.10. CSPC Pharmaceutical Group Ltd.
• 31.11. Patheon
• 31.12. Dr. Reddy's Laboratories Ltd.
• 31.13. Siegfried Ltd.
• 31.14. Recipharm AB
• 31.15. Shandong Lukang Pharmaceutical Co. Ltd.

32. Global Microbial API Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Microbial API Market

34. Recent Developments In The Microbial API Market

35. Microbial API Market High Potential Countries, Segments and Strategies

• 35.1 Microbial API Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Microbial API Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Microbial API Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료